• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真实世界乳腺癌实践中的远程症状警报与患者报告结局(PROs):用于推导症状负担和生活质量的创新数据

Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life.

作者信息

Rusli Emelly, Wujcik Debra, Galaznik Aaron

机构信息

Carevive by HealthCatalyst, Boston, MA 02110, USA.

出版信息

Bioengineering (Basel). 2024 Aug 19;11(8):846. doi: 10.3390/bioengineering11080846.

DOI:10.3390/bioengineering11080846
PMID:39199802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351372/
Abstract

Treatment for breast cancer (BC) can lead to debilitating symptoms that can reduce outcomes and quality of life (QoL). Symptom surveillance using a remote symptom monitoring (RSM) platform enables the capture and reporting of patient-reported outcomes (PROs) from home. Women with BC used an RSM platform to complete weekly surveys and report any symptoms experienced during treatment. Symptoms reported as moderate/severe generated alerts to the clinical team. Clinical actions in response to the alert were captured. Results highlighted the value of data generated from a PRO-generated alert system to characterize longitudinal symptom burden and QoL in real-world BC practice, particularly in patients with poor functional status. The most prevalent symptoms that resulted in alerts were pain, nausea/vomiting, neuropathy, fatigue, and constipation. Most women reported one or more moderate/severe symptoms that generated an alert with an average of two alerts per week. Patients with frail status had more alerts, worse QoL and higher treatment bother, indicating that frail patients may benefit from continuous monitoring of symptoms, function, and QoL over time. A case study of patients without pre-existing peripheral neuropathy showed the rapid trajectory from the first report of mild neuropathy until alerts were generated, making a case for early intervention.

摘要

乳腺癌(BC)的治疗可能会导致使人虚弱的症状,进而降低治疗效果和生活质量(QoL)。使用远程症状监测(RSM)平台进行症状监测能够在家中获取并报告患者报告结局(PROs)。患有BC的女性使用RSM平台完成每周的调查,并报告治疗期间经历的任何症状。报告为中度/重度的症状会向临床团队发出警报。记录针对警报采取的临床行动。结果凸显了由PRO生成的警报系统所产生的数据在真实世界的BC治疗实践中用于描述纵向症状负担和生活质量的价值,尤其是在功能状态较差的患者中。导致发出警报的最常见症状为疼痛、恶心/呕吐、神经病变、疲劳和便秘。大多数女性报告了一种或多种中度/重度症状并触发了警报,平均每周有两次警报。身体虚弱的患者警报更多、生活质量更差且治疗困扰更大,这表明虚弱患者可能会受益于对症状、功能和生活质量的长期持续监测。一项针对无既往周围神经病变患者的案例研究显示了从首次报告轻度神经病变到发出警报的快速发展过程,这为早期干预提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/6d6d4d1ad5f3/bioengineering-11-00846-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/56ad3d41c7d8/bioengineering-11-00846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/41ed315ad4d4/bioengineering-11-00846-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/de98e78baf2f/bioengineering-11-00846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/f3fcc392d6c8/bioengineering-11-00846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/309f504bb8c0/bioengineering-11-00846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/8e8d2321bfd3/bioengineering-11-00846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/e80a92f9c417/bioengineering-11-00846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/6d6d4d1ad5f3/bioengineering-11-00846-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/56ad3d41c7d8/bioengineering-11-00846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/41ed315ad4d4/bioengineering-11-00846-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/de98e78baf2f/bioengineering-11-00846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/f3fcc392d6c8/bioengineering-11-00846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/309f504bb8c0/bioengineering-11-00846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/8e8d2321bfd3/bioengineering-11-00846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/e80a92f9c417/bioengineering-11-00846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b4a/11351372/6d6d4d1ad5f3/bioengineering-11-00846-g008.jpg

相似文献

1
Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life.真实世界乳腺癌实践中的远程症状警报与患者报告结局(PROs):用于推导症状负担和生活质量的创新数据
Bioengineering (Basel). 2024 Aug 19;11(8):846. doi: 10.3390/bioengineering11080846.
2
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39).电子患者报告结局(ePRO)远程症状监测系统(AFT-39)中警报通知的优化。
Qual Life Res. 2024 Jul;33(7):1985-1995. doi: 10.1007/s11136-024-03675-3. Epub 2024 May 21.
3
Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast Cancer.评估远程症状监测计划中乳腺癌患者严重程度和癌症分期对护士响应时间的影响。
JCO Clin Cancer Inform. 2023 Jun;7:e2300015. doi: 10.1200/CCI.23.00015.
4
Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39).肺癌化疗期间的电子患者报告结局监测:实用临床试验(AFT-39)中的嵌套队列。
Lung Cancer. 2021 Dec;162:1-8. doi: 10.1016/j.lungcan.2021.09.020. Epub 2021 Sep 30.
5
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.成人抗肿瘤治疗后症状远程监测项目分析。
JAMA Netw Open. 2022 Mar 1;5(3):e221078. doi: 10.1001/jamanetworkopen.2022.1078.
6
Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study.门诊多发性骨髓瘤患者报告症状监测及其后续临床干预的依从性:纵向观察研究。
J Med Internet Res. 2023 Aug 22;25:e46017. doi: 10.2196/46017.
7
Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevance.远程症状监测系统背景下的实时症状管理:前瞻性过程评估和横断面调查,以探索临床相关性。
Support Care Cancer. 2021 Jun;29(6):3401-3408. doi: 10.1007/s00520-021-06029-8. Epub 2021 Jan 30.
8
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.自动化症状警报可降低癌症手术后的症状严重程度:一项随机对照临床试验。
J Clin Oncol. 2011 Mar 10;29(8):994-1000. doi: 10.1200/JCO.2010.29.8315. Epub 2011 Jan 31.
9
Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer.远程症状监测(RSM)在转移性前列腺癌治疗中老年患者中的可行性和可接受性。
J Geriatr Oncol. 2023 Apr;14(3):101469. doi: 10.1016/j.jgo.2023.101469. Epub 2023 Mar 12.
10
A PRO-cision medicine intervention to personalize cancer care using patient-reported outcomes: intervention development and feasibility-testing.采用患者报告结局进行精准医学干预以实现癌症个体化护理:干预措施的制定和可行性测试。
Qual Life Res. 2022 Aug;31(8):2341-2355. doi: 10.1007/s11136-022-03093-3. Epub 2022 Feb 8.

引用本文的文献

1
Deep Learning Approaches to Forecast Physical and Mental Deterioration During Chemotherapy in Patients with Cancer.深度学习方法预测癌症患者化疗期间身心衰退情况
Diagnostics (Basel). 2025 Apr 9;15(8):956. doi: 10.3390/diagnostics15080956.

本文引用的文献

1
Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: the importance of getting it right.在癌症治疗期间实施电子患者报告结局用于症状监测:正确实施的重要性。
J Comp Eff Res. 2023 Dec;12(12):e230157. doi: 10.57264/cer-2023-0157. Epub 2023 Nov 14.
2
Prevalence and predictors of peripheral neuropathy after breast cancer treatment.乳腺癌治疗后周围神经病变的患病率及预测因素
Cancer Med. 2021 Oct;10(19):6666-6676. doi: 10.1002/cam4.4202. Epub 2021 Aug 14.
3
Pain Management in Breast Cancer Patients: A Multidisciplinary Approach.
乳腺癌患者的疼痛管理:多学科方法
Cureus. 2021 Jun 28;13(6):e15994. doi: 10.7759/cureus.15994. eCollection 2021 Jun.
4
Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review.乳腺癌患者在不同治疗阶段的症状群:系统评价。
Cancer Med. 2021 Apr;10(8):2531-2565. doi: 10.1002/cam4.3794. Epub 2021 Mar 21.
5
Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing.使用患者报告的结局和定量感觉测试来描述化疗引起的周围神经病。
Breast Cancer Res Treat. 2021 Apr;186(3):761-768. doi: 10.1007/s10549-020-06079-2. Epub 2021 Jan 28.
6
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).国家癌症研究所患者报告结局版通用不良事件术语标准(PRO-CTCAE)的综合分级算法。
Clin Trials. 2021 Feb;18(1):104-114. doi: 10.1177/1740774520975120. Epub 2020 Dec 1.
7
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial.常规癌症护理中电子患者报告症状监测数字系统的临床实用性和用户认知:来自 PRO-TECT 试验的结果。
JCO Clin Cancer Inform. 2020 Oct;4:947-957. doi: 10.1200/CCI.20.00081.
8
Addressing frailty in patients with breast cancer: A review of the literature.探讨乳腺癌患者的衰弱问题:文献回顾。
Eur J Surg Oncol. 2020 Jan;46(1):24-32. doi: 10.1016/j.ejso.2019.08.011. Epub 2019 Aug 12.
9
Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review.用于患者报告和管理癌症治疗副作用的电子系统:系统评价
J Med Internet Res. 2019 Jan 24;21(1):e10875. doi: 10.2196/10875.
10
Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy.癌症治疗副作用患者报告的单一项目测量的有效性和有用性。
Cancer. 2018 Mar 1;124(5):991-997. doi: 10.1002/cncr.31133. Epub 2017 Nov 13.